Undersized donor hearts were indeed associated with more post-transplantation mortality -- but only among complex transplant ...

The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

PR-15 is under clinical development by advanceCor and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart Disease).

Heart Hospital has expanded its use of surgical robots incoronary artery bypass grafting (Robotic CABG) surgeries.

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with ...

The deposition of this mineral on plaques in our heart arteries can contribute to chest pain and heart attacks.

Heart Hospital has expanded its use of surgical robots in coronary artery bypass grafting (Robotic CABG) ...

MS patients show large differences between vascular age and chronological age, even if they don't have cardiovascular disease ...

Orticumab is under development for the treatment of acute coronary syndrome and coronary inflammation. The drug candidate is administered intravenously. It is developed based on F.I.R.S.T Technology.

The catheterization lab has an interventional tool that uses ultrasound shockwaves to strike coronary artery calcium.